Skip to content

Study of Osteopathic Manipulation in the Management of Angina

Study of Osteopathic Manipulation in the Management of Angina

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00708279
Acronym
SOMMA
Enrollment
1
Registered
2008-07-02
Start date
2007-08-31
Completion date
2008-07-31
Last updated
2011-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina Pectoris

Keywords

angina pectoris, osteopathic manipulation

Brief summary

The purpose of this study is to assess the effectiveness of osteopathic manipulation in decreasing angina pectoris symptoms.

Interventions

Participant will be evaluated and treated for somatic dysfunction utilizing osteopathic manipulation once a week for 3 weeks, then once every 3 weeks for three more visits; a total of 6 interventions in 3 months.

Sponsors

Osteopathic Heritage Foundations
CollaboratorOTHER
University of New England
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 81 Years
Healthy volunteers
No

Inclusion criteria

* Canadian Cardiovascular Society Class II, III for a minimum of 6 months * documented coronary artery disease via previous myocardial infarction, abnormal stress test, or abnormal coronary angiogram of greater than or equal to 50% luminal obstruction of at least one epicardial vessel.

Exclusion criteria

* severe left ventricular dysfunction * symptomatic heart failure * symptomatic aortic stenosis or any valvular disease * significant pulmonary disease * unstable angina * major surgery or angioplasty in the past three months * acute myocardial infarction within past three months * insulin dependent diabetes mellitus * uncontrolled hypertension * acute renal or hepatic failure * currently being treated with osteopathic manipulation

Design outcomes

Primary

MeasureTime frame
Decrease in angina symptomsover 4 month period

Secondary

MeasureTime frame
Improvement in quality of lifeover 4 month period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026